Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Bavarian Nordic National Institute of Allergy and Infectious Diseases (NIAID) |
---|---|
Information provided by: | Bavarian Nordic |
ClinicalTrials.gov Identifier: | NCT00189904 |
The purpose of this study is to gather information on the safety and immunogenicity of an investigational smallpox vaccine in HIV infected populations.
Condition | Intervention | Phase |
---|---|---|
HIV Infections |
Biological: IMVAMUNE (MVA-BN) |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment |
Official Title: | A Multicenter, Open-Label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350
|
Estimated Enrollment: | 150 |
Study Start Date: | July 2005 |
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Groups 1 and 3 (All vaccinia-naïve subjects) additionally:
Groups 2 and 4 (All previously vaccinated subjects) additionally:
Groups 1 and 2 (All HIV Infected subjects) additionally:
Groups 3 and 4 (All Healthy subjects) additionally:
Exclusion Criteria:
United States, Indiana | |
Indiana University School of Medicine | |
Indianapolis, Indiana, United States, 46202-2859 | |
United States, Kentucky | |
University of Kentucky Medical Center | |
Lexington, Kentucky, United States, 40536-0093 | |
United States, Missouri | |
Washington University School of Medicine | |
St.Louis, Missouri, United States | |
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104-6073 | |
United States, Tennessee | |
Vanderbilt AIDS Clinical Trials Center | |
Nashville, Tennessee, United States, 37203 |
Principal Investigator: | Richard N Greenberg, M.D. | University of Kentucky School of Medicine |
Responsible Party: | Bavarian Nordic ( Monika Fluer ) |
Study ID Numbers: | POX-MVA-010, HHSN266200400072C |
Study First Received: | September 11, 2005 |
Last Updated: | February 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00189904 History of Changes |
Health Authority: | United States: Food and Drug Administration |
HIV |
Virus Diseases Smallpox Sexually Transmitted Diseases, Viral Poxviridae Infections HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome DNA Virus Infections Healthy Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Sexually Transmitted Diseases, Viral Slow Virus Diseases Immune System Diseases Acquired Immunodeficiency Syndrome Infection Immunologic Deficiency Syndromes Smallpox |
Virus Diseases Poxviridae Infections HIV Infections Sexually Transmitted Diseases Lentivirus Infections DNA Virus Infections Retroviridae Infections |